Key result
A clinical decision rule combining the Marburg Heart Score and a high-sensitivity troponin point-of-care test safely ruled out acute coronary syndrome with 98.3% sensitivity, though it did not reduce emergency department referrals compared to usual care.
Why the study?
Accurate risk stratification of patients with chest pain in primary care may improve patient safety while reducing unnecessary hospital referrals.
Does a clinical decision rule combining the Marburg Heart Score and a point-of-care hs-cTnI test safely rule out acute coronary syndrome in primary care patients with chest pain?
RCT (n=827)
Open-label
Cluster-randomised (2:1)
Yes
Does a clinical decision rule combining the Marburg Heart Score and a point-of-care hs-cTnI test safely rule out acute coronary syndrome in primary care patients with chest pain?
Answers are grounded in this paper and cite their sources.
A clinical decision rule combining the Marburg Heart Score with a point-of-care high-sensitivity troponin I test can safely rule out acute coronary syndrome in primary care, though it did not significantly reduce hospital referrals in this trial.
Background Accurate risk stratification of patients with chest pain in primary care may improve patient safety while reducing unnecessary hospital referrals. Aim To evaluate the diagnostic performance of a clinical decision rule (CDR) combining high-sensitivity tro-ponin I (hs-cTnI) and the Marburg Heart Score (MHS) to rule out acute coronary syndrome (ACS), and specifically myocardial infarction (MI), in primary care patients with chest pain, and to compare referral rates with usual care. Design and setting Cluster-randomised diagnostic trial (2:1 intervention:control) conducted in Dutch primary care practices. Method Patients presenting with acute chest pain were assessed using a CDR applied by general practitioners, combining the MHS with a hs-cTnI point-of-care test. General practitioners in the control group provided usual care. Diagnostic performance was evaluated using sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV). Secondary endpoints included evaluation of a modified HEART score and single hs-cTnI rule-out strategy. Results In total, 827 participants were included: 740 intervention and 87 controls. The CDR missed one ACS, yielding a sensitivity of 98.3% (95% CI 90.8-100%) and NPV of 99.7% (95% CI 98.0-100%). Specificity was 49.1% (95% CI 45.3-52.9%) and PPV 14.1% (95% CI 13.2-15.1%). For MI, sensitivity and NPV were both 100% (95% CI 92.6-100% and 95% CI 98.9-100%, respectively). Specificity was 48.6% (95% CI 44.8-52.4%), and PPV 11.9% (95% CI 11.1-12.7%). Referral rates did not differ significantly between groups (54.6% vs 47.1%; p=0.39). Conclusion A CDR combining the MHS with a hs-cTnI point-of-care test safely ruled out ACS and MI in(..)
No takes yet. Share an insight, caveat, or question.
Bulk et al. (2026) conducted an RCT in Acute chest pain suggestive of acute coronary syndrome (n=827). Clinical decision rule (Marburg Heart Score and hs-cTnI point-of-care test) vs. Usual care was evaluated on Emergency department referral rate (p=0.39). A clinical decision rule combining the Marburg Heart Score and a high-sensitivity troponin point-of-care test safely ruled out acute coronary syndrome with 98.3% sensitivity, though it did not reduce emergency department referrals compared to usual care.
Synapse has enriched 10 related papers. Consider them for comparative context: